ImmunoPrecise Antibodies (IPA) Institutional Ownership $1.64 -0.02 (-1.20%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.58 -0.05 (-3.35%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$246.01KNumber ofInstitutional Sellers(last 12 months)0 Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/31/2025 Ingalls & Snyder LLC2,779,363$2.95M0.1%+0.8%6.074% 7/10/2025 Baader Bank Aktiengesellschaft26,961$29K0.0%N/A0.059% 11/15/2024 Ingalls & Snyder LLC1,558,892$996K0.0%+20.3%5.407% 8/9/2024Renaissance Technologies LLC63,910$65K0.0%+70.0%0.243% 1/29/2024 Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023 Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023Bank of Montreal Can208,110$668K0.0%N/A0.831% 5/9/2023 Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 1/31/2023 Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022 Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% 10/21/2022 Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022 Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022 Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022 Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021 Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021 Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% (Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($2.95M), Bank of Montreal Can ($668K), Renaissance Technologies LLC ($65K), and Baader Bank Aktiengesellschaft ($29K), Rathbones Group PLC ($26K).Learn more on ImmunoPrecise Antibodies' institutional investors. What percentage of ImmunoPrecise Antibodies' stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies' stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies' stock? The following institutional investors have purchased ImmunoPrecise Antibodies' stock in the last 24 months: Ingalls & Snyder LLC ($537.74K), Bank of Montreal Can ($208.11K), Baader Bank Aktiengesellschaft ($26.96K), Renaissance Technologies LLC ($26.31K), and Rathbones Group PLC ($14K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 337,958 shares in the last 24 months. This purchase volume represents approximately $246.01K in transactions. Related Companies Capricor Therapeutics Major Shareholders Cartesian Therapeutics Major Shareholders Olema Pharmaceuticals Major Shareholders ADC Therapeutics Major Shareholders Neumora Therapeutics Major Shareholders Ocugen Major Shareholders Heron Therapeutics Major Shareholders Kodiak Sciences Major Shareholders Corvus Pharmaceuticals Major Shareholders Benitec Biopharma Major Shareholders This page (NASDAQ:IPA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
